AF: The 25% Diabetes Complication You Miss 02/13/26
Welcome to Cardiology Today â Recorded February 13, 2026. This episode summarizes 5 key cardiology studies on topics like obesity and body mass index. Key takeaway: AF: The 25% Diabetes Complication You Miss.
Article Links:
Article 1: Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. (Circulation)
Article 2: Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration. (Circulation)
Article 3: Atrial fibrillation: an underappreciated complication of diabetes. (European heart journal)
Article 4: Left Atrial Volumetric Enlargement in Heart Failure With Reduced Ejection Fraction: Obligatory Consequence or Independent Predictor of Outcome? (JACC. Heart failure)
Article 5: Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary Compliance. (JACC. Heart failure)
Full episode page: https://podcast.explainheart.com/podcast/af-the-25-diabetes-complication-you-miss-02-13-26/
đ Featured Articles
Article 1: Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.
Journal: Circulation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41674449
Summary: C. R. A. B. L. Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. An increasing link between B. C. R. A. B. L. tyrosine kinase inhibitors and pulmonary arterial hypertension has been recognized since 2009. This study precisely evaluated the risk of pulmonary arterial hypertension associated with second- and third-generation inhibitors compared to imatinib in adults. Utilizing the French national health care database, researchers established a robust prevalent new-user design which identified patient cohorts initiating these treatments between 2008 and 2024. The investigation offered a critical framework to quantify this potential adverse event for clinical practice.
Article 2: Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
Journal: Circulation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41674444
Summary: Obesity is a confirmed risk factor for cardiovascular disease, with specific relationships across the full spectrum of body mass index, including severe obesity, requiring further characterization. The Cross-Cohort Collaboration definitively described the prospective associations of obesity and its severity with nine specific cardiovascular outcomes. This comprehensive analysis included 289875 participants, comprising 79 point 2 percent women, from 21 distinct cohorts enrolled between 1948 and 2017. The study provides an extensive dataset essential for understanding long-term cardiovascular disease risks across various obesity classes.
Article 3: Atrial fibrillation: an underappreciated complication of diabetes.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41668366
Summary: Atrial fibrillation is identified as a significant complication of diabetes, demonstrating a prevalence of up to 25 percent in individuals with the condition. The incidence rates of atrial fibrillation are increasing among patients with diabetes. This development of atrial fibrillation in diabetic individuals occurs independently of other risk factors such as hypertension, atherosclerotic cardiovascular disease, or heart failure. The pathogenesis involves multifactorial atrial structural, electrical, and autonomic remodeling directly linked to diabetes.
Article 4: Left Atrial Volumetric Enlargement in Heart Failure With Reduced Ejection Fraction: Obligatory Consequence or Independent Predictor of Outcome?
Journal: JACC. Heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41677478
Summary: This study definitively investigated the independent association between left atrial volume index and long-term mortality in patients with heart failure. The research specifically considered its interaction with the severity of functional mitral regurgitation, establishing a crucial assessment framework for this relationship. The investigation provided a comprehensive approach to understanding the prognostic implications of left atrial volume index in this patient population.
Article 5: Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary Compliance.
Journal: JACC. Heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41677477
Summary: F. pEF: Impact of Reduced Atriopulmonary Compliance. Approximately one-third of patients with heart failure with preserved ejection fraction demonstrate normal resting pulmonary capillary wedge pressure, yet experience left atrial hypertension exclusively during exercise. This study thoroughly investigated the clinical course of these patients presenting with exercise-induced left atrial hypertension. The research explored whether this condition represents a distinct heart failure with preserved ejection fraction phenotype or an earlier stage that progresses to resting left atrial hypertension over time. This investigation provided critical insights into the natural history and progression of left atrial hypertension in heart failure with preserved ejection fraction.
đ Transcript
Today’s date is February 13, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Second- and Third-Generation B. C. R. A. B. L. Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. An increasing link between B. C. R. A. B. L. tyrosine kinase inhibitors and pulmonary arterial hypertension has been recognized since 2009. This study precisely evaluated the risk of pulmonary arterial hypertension associated with second- and third-generation inhibitors compared to imatinib in adults. Utilizing the French national health care database, researchers established a robust prevalent new-user design which identified patient cohorts initiating these treatments between 2008 and 2024. The investigation offered a critical framework to quantify this potential adverse event for clinical practice.
Article number two. Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration. Obesity is a confirmed risk factor for cardiovascular disease, with specific relationships across the full spectrum of body mass index, including severe obesity, requiring further characterization. The Cross-Cohort Collaboration definitively described the prospective associations of obesity and its severity with nine specific cardiovascular outcomes. This comprehensive analysis included 289875 participants, comprising 79 point 2 percent women, from 21 distinct cohorts enrolled between 1948 and 2017. The study provides an extensive dataset essential for understanding long-term cardiovascular disease risks across various obesity classes.
Article number three. Atrial fibrillation: an underappreciated complication of diabetes. Atrial fibrillation is identified as a significant complication of diabetes, demonstrating a prevalence of up to 25 percent in individuals with the condition. The incidence rates of atrial fibrillation are increasing among patients with diabetes. This development of atrial fibrillation in diabetic individuals occurs independently of other risk factors such as hypertension, atherosclerotic cardiovascular disease, or heart failure. The pathogenesis involves multifactorial atrial structural, electrical, and autonomic remodeling directly linked to diabetes.
Article number four. Left Atrial Volumetric Enlargement in Heart Failure With Reduced Ejection Fraction: Obligatory Consequence or Independent Predictor of Outcome? Left atrial remodeling, specifically progressive enlargement, is a common observation in heart failure with reduced ejection fraction and reflects left ventricular dysfunction and functional mitral regurgitation. This study definitively investigated the independent association between left atrial volume index and long-term mortality in patients with heart failure. The research specifically considered its interaction with the severity of functional mitral regurgitation, establishing a crucial assessment framework for this relationship. The investigation provided a comprehensive approach to understanding the prognostic implications of left atrial volume index in this patient population.
Article number five. Progression From Exercise-Induced to Resting Left Atrial Hypertension in H. F. pEF: Impact of Reduced Atriopulmonary Compliance. Approximately one-third of patients with heart failure with preserved ejection fraction demonstrate normal resting pulmonary capillary wedge pressure, yet experience left atrial hypertension exclusively during exercise. This study thoroughly investigated the clinical course of these patients presenting with exercise-induced left atrial hypertension. The research explored whether this condition represents a distinct heart failure with preserved ejection fraction phenotype or an earlier stage that progresses to resting left atrial hypertension over time. This investigation provided critical insights into the natural history and progression of left atrial hypertension in heart failure with preserved ejection fraction.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
obesity, body mass index, cardiovascular disease, imatinib, functional mitral regurgitation, pathogenesis, resting left atrial hypertension, long-term mortality, heart failure with reduced ejection fraction, atriopulmonary compliance, severe obesity, prognostic significance, exercise-induced left atrial hypertension, pulmonary capillary wedge pressure, prevalence, incidence, diabetes, drug adverse events, atrial fibrillation, drug safety, pulmonary arterial hypertension, heart failure with preserved ejection fraction, left atrial enlargement, long-term outcomes, B. C. R. A. B. L. tyrosine kinase inhibitors.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow